Faculty of Medicine news
McGill Newsroom Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections. Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.
McGill Newsroom Pioneering research at McGill’s Goodman Cancer Research Centre gets boost The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients. The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of McGill University’s Rosalind and Morris Goodman Cancer Research Centre.
Raising awareness about stroke Every ten minutes, someone in Canada suffers a stroke. Strokes kill 14,000 Canadians each year, making stroke the third leading cause of death in this country. The Montreal Neurological Institute and Hospital (The Neuro) hopes to increase public awareness about the dangers of stroke by marking Stroke Month. People who learn about the causes of stroke can take measures to reduce their chances of having a stroke. What is a stroke?
Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
McGill Newsroom McGill alumnus tagged to boost capacity and discovery in growing field Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
McGill Newsroom Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
McGill University Health Centre New study reinforces importance of implementing screening in Quebec
McGill Newsroom Discovery offers hope for more effective treatments of deadly glioblastomas A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.
McGill Newsroom To support six research projects in fields from neuroscience to food safety and Arctic ecosystems
McGill Newsroom CREATE project to prepare graduates for high-skills work in surgical-devices industry A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.
By Fergus Grieve, McGill Newsroom Depression, metabolic factors combine to boost risk of developing diabetes, study finds Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
McGill University Health Centre
By Tod Hoffman, Lady Davis Institute Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform